Akorn (AKRX)
Add to Watchlists Create an Alert
14.55
-0.28 -1.89%
NASDAQ
May 22, 8:00PM
BATS Real time
Currency in USD
Akorn Cash from Financing Quarterly:
1.106M for Dec. 31, 2012Akorn Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.106M |
| Dec. 31, 2012 | 2.987M |
| Sept. 30, 2012 | 1.261M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 2.118M |
| Dec. 31, 2011 | 0.054M |
| Sept. 30, 2011 | 0.02M |
| June 30, 2011 | 115.54M |
| March 31, 2011 | 2.106M |
| Dec. 31, 2010 | -6.152M |
| Sept. 30, 2010 | 0.215M |
| June 30, 2010 | 2.542M |
| March 31, 2010 | -0.436M |
| Dec. 31, 2009 | -4.487M |
| Sept. 30, 2009 | 2.016M |
| June 30, 2009 | 0.009M |
| March 31, 2009 | 5.451M |
| Dec. 31, 2008 | -6.783M |
| Sept. 30, 2008 | 1.212M |
| June 30, 2008 | 2.786M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
AKRX Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Mylan | 6.599M |
| Dr. Reddy Laboratories | 7.192M |
| Teva Pharmaceutical Industries | -2.26B |
AKRX Cash from Financing Quarterly Rankings
| Overall |
83rd percentile 1288 of 8005 |
| Sector |
73rd percentile 185 of 686 in Healthcare |
| Industry |
69th percentile 21 of 68 in Drug Manufacturers - Specialty & Generic |
AKRX Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -6.783M | Dec 2008 |
| Maximum | 115.54M | Jun 2011 |
| Average | 6.078M |